1. European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertension 2003; 21: 1011–153.
2. Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28: 1462–536.
3. Chobanian AN, Bakris GL, Black HR et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206–52.
4. Lindheimer MD, Katz AI. Hypertension in pregnancy: advances and controversies. Clin Nephrol 1991; 36: 166–73.
5. Cunningham FG, Lindheimer MD. Hypertension in pregnancy. New Engl J Med 1992; 326: 927–32.
6. Lindheimer MD. Hypertension in pregnancy. Hypertension 1993; 22: 127–37.
7. Shibai BM. Treatment of hypertension in pregnant women. New Engl J Med 1996; 335(4): 257–65.
8. Brown MA, Davis GK. Hypertension in pregnancy. G.Mancia et al. (eds.) Manual of hypertension. London, 2002: 579–98.
9. Granem FA, Movahed A. Use of Antihypertensive drugs during pregnancy and lactation. Cardiovasc Therap 2008; 26: 38–49.
10. Lydakis C, Lip GYH, Beevers M, Beevers DG. Atenolol and fatal growth in pregnancies complicated by hypertension. Am J Hypertension 1999; 12: 541–7.
11. Lip GYH, Beevers M, Churchill D et al. Effect of atenolol on birth weight. Am J Cardiol 1997; 79(10): 1436–38.
12. Сидоренко Б.А., Преображенский Д.В. Краткий справочник по лечению гипертонической болезни. М.: АОЗТ "Презид", 1997.
13. Биверс Т., Лип Г., О'Брайен. Артериальная гипертония. М.: БИНОМ, 2005.
14. Churchil DC, Beevers DG. Hypertension in pregnancy. London: BMJ Books, 1999.
15. Baughman Kl. The heart and pregnancy. Topol EJ. (ed.). Textbook of cardiovascular medicine. Third edition. Philadelphia, 2007: 537–52.
16. Magee LA, Schick B, Donnenfeld AE et al. The safety of calcium channel blockers in human pregnancy: A prospective, multicenter cohort study. Am J Obstet Gynecol 1996; 174: 823–8.
17. Akbari A, Lindheimer MD. Management of high blood pressure in pregnancy. Epstein M. (ed.) Calcium antagonists in clinical medicine. 2 ed. Philadelphia, 1998: 321–44.
18. Opie LH. Angiotensin Converting Enzyme Inhibitors. 3th ed. New York, 1999.
19. Сидоренко Б.А., Преображенский Д.В., Батыралиев Т.А. Ингибиторы ангиотензинпревращающего фермента. М.: Литтерра, 2007.
20. Hanssens M, Keirse MJ, Vankelecom F, van Assche FA. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol 1991; 78: 128–35.
21. Shotan A, Widerhorn J, Hurst A et al. Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use. Am J Med 1994; 96: 451–6.
22. Martinovic J, Benachi A, Laurent N et al. Fetal toxic effects and angiotensin-II-receptor antagonists. Lancet 2001; 358: 241–2.
23. Сooper W, Hernandez-Diaz S, Argogast PG et al. Mayor congenital malformations after first-trimester exposure to ACE inhibitirs. New Engl J Med 2006; 354: 2443–51.